|
|
|
|
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
Background.A 58-year-old man who had a 35-year history of Crohn's disease presented to our IBD center with a disease flare, pararectal fistulas and abscess formation. The patient had previously undergone ileocolic resection for a...
Nature Reviews Gastroenterology & Hepatology:
Jul 3 2009 11:37AM
Matching: lymphoma t cell
|
Find similar documents
|
|
|
|
Patients with extensive limb disease have worse pcALCL prognosis
MedWire News: Patients with primary cutaneous anaplastic large cell lymphoma (pcALCL) and extensive limb disease (ELD) have a more aggressive disease course and a differential gene expression profile to other patients with the...
|
|
|
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
_ Hepatosplenic T-cell lymphoma in a patient with Crohn's disease.
Nature Clinical Practice Gastroenterology & Hepato:
Jul 3 2009 10:08AM
Matching: lymphoma t cell
|
Find similar documents
|
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical...
|
|
|
Prognostic Effect of Lymphocyte Subgroup CD4+ and CD8+ Cells in Peripheral Blood in Renal Transplant Patients
Print Save in My Library Free Abstract Chen JS et al.- The decrease in peripheral blood lymphocyte subgroup CD4+ and CD8+ cells after renal transplantation in patients with CMV viremia showed prognostic value for pneumonia.
|
|
|
PAD prevalent among patients with diabetes, metabolic syndrome
While knowledge of peripheral arterial disease has progressed, much is needed still in the way of comparator trials and efficacy of new diagnostic approaches.Peripheral artery disease also referred to as peripheral vascular disease...
|
|
|
Yaupon Completes Patient Enrollment For Phase-II Study Of Clearazide
Clearazide, for the treatment of Cutaneous T-cell Lymphoma Yaupon has completed enrollment for a pivotal phase-II clinical trial for Clearazide, for the treatment of early-stage cutaneous T-cell lymphoma ...
|
|
|
Damon Runyon Cancer Research Foundation Awards $2.7M To 7 Top Young Clinical Investigators
The Damon Runyon Cancer Research Foundation named 4 new Damon Runyon Clinical Investigators at its April 2009 Clinical Investigator Award Committee review.The recipients of this prestigious, three-year award are outstanding early career...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment For Pivotal Phase 2 Study Of Clearazide For Treatment Of Cuta
Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced it has completed enrollment for a pivotal Phase 2 clinical trial for Clearazide for the treatment of early-stage cutaneous T-cell lymphoma...
|
|
|
Damon Runyon Cancer Research Foundation awards $2.7M to 7 top young clinical investigators
New York, NY -- The named 4 new Damon Runyon Clinical Investigators at its April 2009 Clinical Investigator Award Committee review.The recipients of this prestigious, three-year award are outstanding early career physician-scientists...
|
|
|
Yaupon Therapeutics Inc. Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa.The randomized, double-blind, controlled clinical study is the largest ever undertaken...
|
|
|
Adventures in Cancerland, Part 1: The diagnosis
Editor's note: Mike Celizic is TODAYshow.coms ace morning news reporter as well as a sports columnist for msnbc.com.He is known for his ability to write compelling, accurate stories at lightning speed, as well as for his trademark hat,...
|
|
|
TopAbstracts in Smoking Related Disorders 06/22/2009
Recent news - Smoking Related Disorders TopAbstracts in Smoking Related Disorders 06/08/2009- (DGNews) Study Redefines Roles of Alcohol, Smoking in Risk for Pancreatitis- (DGNews) Mutation Status Appears to Predict Response to First-Line...
|
|
|
[Pediatric Oncology] Minimal Disseminated Disease in Childhood T-Cell Lymphoblastic Lymphoma: A Report From th
This Article Google Scholar Social Bookmarking Received November 20, 2008 Accepted February 4, 2009 Elaine Coustan-Smith, John T.Sandlund, Sherrie L. Perkins, Helen Chen, Myron Chang, Minnie Abromowitch, and Dario Campana* From...
|
|
|
Primary Cutaneous T-Cell Lymphoma Localized to the Lower Leg
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Archives of Dermatology, 06/22/09 Print Save in My Library Free Abstract Poligone B et al.- Rare cases of primary cutaneous lymphomas do not...
|
|
|
ZIOPHARM Presents Positive Darinaparsin Clinical Data at ASCO??s Prestigious Clinical Science Symposium
ZIOPHARM Oncology, Inc.(Nasdaq: ZIOP) announced that it presented positive data from both Phase II intravenous (IV) and Phase I oral studies of darinaparsin (ZinaparTM or ZIO-101), the novel organic arsenic molecule, as part of the...
|
|
|
The B-cell Compartment in the Peripheral Blood of Children With Different Types of Primary Humoral Immunodefic
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Pediatric Research, 06/19/09 Print Save in My Library Free Abstract Bukowska-Ukowska K et al.- No significant differences in the level of memory B ...
|
|
|
Interleukin-2: Trials and Tribulations; IL-2 Fails Again, EDITORIAL COMMENTARY
Daniel R.Kuritzkes Section of Retroviral Therapeutics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts Received 3 April 2009; accepted 7 April 2009; electronically published 9 June 2009. (See the article...
National AIDS Treatment Advocacy Project:
Jun 18 2009 11:49AM
Matching: lymphoma t cell
|
Find similar documents
|
|
|
|
Skin Disorders in Older Adults: Vascular, Lymphatic, and Purpuric Dermatitides, Part 1
Solar purpura, cherry angiomas, venous lakes, varicose veins, and spider telangiectasia result from age-related changes in the blood vessels, the lymphatics, and the ground substance.The cause of benign pigmented purpura is unclear. Sun...
|
|
|
Peripheral Nerve Repair With Fat Precursor Cells Led To Wider Nerves And Less Muscle Atrophy
To determine if guided fat (adipose) precursor cells (APCs) could improve nerve regeneration and functional recovery, researchers at the University of Pittsburgh (USA) used biodegradable nerve guides to transplant APCs into the injured...
|
